MENU
Logo Made in Germany BIO 2017

News & Innovations

News and innovations published by German exhibitors

Anavex Life Sciences Expands with Promising Alzheimer Treatment to Bavaria

The New York-based Anavex Life Sciences Corp. (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system diseases, pain and various types of cancer expanded to Martinsried (Munich, Bavaria) in December 2016.

Exhibitor: Bavarian U.S. Offices for Economic Development, LLC East Coast Division

ChemCon celebrates 20th anniversary

ChemCon GmbH, based in Freiburg, Germany, celebrates its 20th anniversary in 2017. On January 29 in 1997, Dr. Raphael Vogler (CEO) and Dr. Peter Gockel (CSO) signed the contract to found ChemCon. Today they count over 90 members of staff, and ChemCon supplies customers of the pharmaceutical...

Exhibitor: ChemCon GmbH

Scientists discover new mechanisms of early metastatic spread in breast cancer

(Hannover/Regensburg, Germany) Scientists of the Regensburg-based Project Group for Personalized Tumor Therapy (Fraunhofer ITEM/University of Regensburg) and colleagues from Icahn School of Medicine at Mount Sinai discovered new mechanisms of early metastatic spread in breast cancer. Results...

Exhibitor: Fraunhofer Institute for Toxicology and Experimental Medicine ITEM

Fraunhofer ITEM takes over and continues development of inhalation technology assets from Takeda

(Hannover, Germany) The Fraunhofer-Gesellschaft, on behalf of the Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, has signed an asset transfer agreement with Takeda GmbH to exclusively transfer its Surfactant and Continuous Powder Aerosolization (CPA) program assets to...

Exhibitor: Fraunhofer Institute for Toxicology and Experimental Medicine ITEM

DNA-Test for detection of influenza viruses H5N8 and H5N6.

Genekam Biotechnology AG has just developed two different kits for two different viruses, which are breaking out in many countries. H5N6 is infecting human beings also particularly a few cases are being reported in China and it may spread to our countries. H5N8 is breaking out in birds at...

Exhibitor: Genekam Biotechnologie AG

World Innovation and Hope: First therapeutic molecule candidate against Zika viruses

Genekam Biotechnology AG, which developed the first test for Zikavrius detection in Januar 2016, has developed as one of first company in the world the therapeutic molecule candidate for Zika viruses, which is likely to be the first potential candidate for Zika-virus therapy. Zika viruses are...

Exhibitor: Genekam Biotechnologie AG

Genekam DNA-Test for detection of yellow fever virus (a new threat to the world)

Genekam Biotechnology AG, Germany has developed a new DNA kit for detection of yellow fever virus. This kit is with CE-IVD and can be used in diagnostic in Europe and other CE accepting countries. At present, there are outbreaks of yellow fever in Africa and WHO is keeping a close eye on...

Exhibitor: Genekam Biotechnologie AG

Comprehensive services

Health Economics & Outcomes Research Value demonstration Dossiers for early benefit assessment and clinical evaluation of drugs Health Technology Assessment (HTA) Market analysis Assessemnt of inpatient and ambulatory sector potentials Competition and regulation...

Exhibitor: IGES Institut GmbH

Linkers and Payloads for Antibody-Drug Conjugation (ADC)

We provide novel payloads with alternative mechanisms of action and innovative and patentable linkers. Besides the standard valine-citrulline type linkers, we can offer novel peptide based fragments, which serve as substrates to cathepsin B or in other type of enzymatic cleavage. Novel types...

Exhibitor: Iris Biotech GmbH

Custom Synthesis of Unusual Amino Acid Analogues

We carry out custom synthesis of complex organic molecules in the domain of our expertise. Standard approaches to yield unusual amino acids via the acetamidomalonate route and asymmetric Strecker synthesis are daily routine in our lab. Additionally we have specific platforms, like asymmetric...

Exhibitor: Iris Biotech GmbH

Custom Synthesis of PEGs and other Polymer Carriers (non-GMP & GMP Production)

With approx. 1000 different polymer carriers we provide the widest portfolio for drug delivery technologies used in polymer therapeutics for small API molecules, as well as for large biopharmaceuticals for latest state-of-the-art application areas like combination therapy and personalized...

Exhibitor: Iris Biotech GmbH

The Medigene Investment Case

Medigene’s immunotherapy programs are deeply rooted in world-class science Established company for biopharmaceutical product development from research to market approval Management team composed of Medigene’s immunotherapies inventors in addition to very experienced...

Exhibitor: Medigene AG

pharmtrace ERICA - GCP-compliant clinical trial image management platform

In 2017 pharmtrace launched its tried and tested GCP-compliant image management system (ERICA) as a “cloud enabled” SaaS ("Software as a Service") platform. ERICA-SaaS empowers customers to directly manage their clinical trial images and to take full control of all imaging-related...

Exhibitor: pharmtrace klinische Entwicklung GmbH

Successful FDA Pre-Approval Inspection

During a total of 7 days of inspection, FDA visited both, the R&D site in Langenfeld as well as the manufacturing facility in Hamburg, Germany. FDA provided feedback with a short list of observations which tesa Labtec takes seriously. At the concluding sessions of the inspections, the FDA...

Exhibitor: tesa Labtec GmbH

Your personal organizer

Your personal organizer

Print list  |  Save as PDF
Xell AG
Booth number: